Prof. Antonio Giordano

University of Siena, Italy

Email: [email protected]

Qualifications

2002-present Director, Sbarro Institute for Cancer Research and Molecular Medicine & Professor of Biology, College of Science and Technology, Temple University, Philadelphia, PA

2001-2002 Professor, Depts. of Pathology, Anatomy & Cell Biology, Jefferson Medical College, Philadelphia, PA

1996-2001 Associate Professor, Depts. of Pathology, Anatomy & Cell Biology Jefferson Medical College, Philadelphia, PA

1994-1996 Assistant Professor, Depts. of Microbiology-Immunology and Pathology, Kimmel Cancer Institute, Jefferson Medical College, Philadelphia, PA

Publications(Selected)

1. Notarangelo, S., Lombardi, M., Lombardi, R., et al. (2026). Endobronchial ultrasound-guided transbronchial fine-needle aspiration of mediastinal lymph nodes: A clinical appraisal of diagnostic accuracy and molecular utility. Current Medical Research and Opinion, 42(2), 335–344.
2. Giordano, A., Graham, N., Aizer, A. A., et al. (2026). A phase II study of atezolizumab in combination with stereotactic radiation for patients with triple-negative breast cancer and brain metastasis. Breast Cancer Research and Treatment, 216(2), Article 24.
3. Salmanton-García, J., Marchesi, F., Mackenzie, E., et al. (2026). Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry. Open Forum Infectious Diseases, 13(3), Article ofag099.
4. Raucci, A., Santillo, A. A., Capelli, L., et al. (2026). Evaluating Hybridization Chain Reaction to Improve miRNA Measurements at Portable Electroanalytical Strip: miRNA-21 as a Case of Study. ACS Omega, 11(7), 11578–11584.
5. Juric, D., Giordano, A., Jhaveri, K., et al. (2026). A phase 1/2 trial of LY4064809 (STX-478), a pan-mutant-selective PI3Kα inhibitor: Updated PIKALO-1 results. Oncology Research and Treatment, 49, 255–255.
6. Sharif, M. S., Luzzi, L., De Laurentiis, M., et al. (2026). Direct pulmonary delivery route in lung cancer: A highway for siRNA therapeutics. Frontiers in Oncology, 15, Article 1722906.
7. Giordano, A., Fianchi, L., Criscuolo, M., et al. (2026). Efficacy and tolerability of mogamulizumab in mycosis fungoides and Sézary Syndrome: A monocentric retrospective study. Frontiers in Oncology, 15, Article 1748746.
8. Salmanton-García, J., Marchesi, F., Navrátil, M., et al. (2026). Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry. American Journal of Hematology, 101(2), 365–375.
9. Mecca, M., Sichetti, M., Spina, E. L., et al. (2025). Darunavir analog precursors target mitochondrial metabolism in multiple myeloma and CLL. Cancer Cell International, 26(1), Article 44.
10. Iannuzzi, C. A., Pagano, F., Tomeo, M., et al. (2025). Caprine herpes virus-1 reduces cell viability and enhances chemosensitivity in breast cancer cells. Frontiers in Oncology, 15, Article 1676296.
11. Scarisbrick, J., Geskin, L., Rozati, S., et al. (2025). Symptom burden and health-related quality of life in patients with Mycosis Fungoides and Sezary Syndrome: Findings from the International PROSPER study. European Journal of Cancer, 229, Article 115929.
12. Mauriello, A., Correra, A., Quagliariello, V., et al. (2025). Atrial Fibrillation and Cancer: Pathophysiological Mechanism and Clinical Implications. Journal of Clinical Medicine, 14(15), Article 5600.
13. Singh, S., Glovi, A., Miglione, A., et al. (2025). Electrochemical (bio)sensors for cancer therapy monitoring. Electrochimica Acta, 537, Article 146929.
14. Di Giulio, V., Canciello, A., Carletti, E., et al. (2025). The dual nature of KLHL proteins: From cellular regulators to disease drivers. European Journal of Cell Biology, 104(2), Article 151483.
15. Caturano, A., Erul, E., Nilo, R., et al. (2025). Insulin resistance and cancer: Molecular links and clinical perspectives. Molecular and Cellular Biochemistry, 480(7), 3995–4014.
16. Di Stefano, M., Piazza, L., Poles, C., et al. (2025). KinasePred: A Computational Tool for Small-Molecule Kinase Target Prediction. International Journal of Molecular Sciences, 26(5), Article 2157.
17. Cafiero, C., Palmirotta, R., Martinelli, C., et al. (2025). Oncological Treatment Adverse Reaction Prediction: Development and Initial Validation of a Pharmacogenetic Model in Non-Small-Cell Lung Cancer Patients. Genes, 16(3), Article 265.
18. Glovi, A., Miglione, A., Maresca, D. C., et al. (2025). Paper-based electrochemical device for the determination of H2S in murine lysates for liquid biopsy application. Analytica Chimica Acta, 1342, Article 343669.
19. Di Stefano, M., Galati, S., Piazza, L., et al. (2024). Watermelon: Setup and validation of an in silico fragment-based approach. Journal of Enzyme Inhibition and Medicinal Chemistry, 39(1), Article 2356179.
20. Mazzarotti, G., Cuomo, M., Ragosta, M. C., et al. (2024). Oleanolic Acid Modulates DNA Damage Response to Camptothecin Increasing Cancer Cell Death. International Journal of Molecular Sciences, 25(24), Article 13475.